NYSE · ASPN

Aspen Aerogels, Inc.

$4.67 -$0.49 (-9.50%) 1D After hours

Key Metrics

$427.65M
Market cap
P/E · TTM
$230.26M
Revenue · TTM
−$111.99M
Net income
EPS · TTM $-1.36
Dividend yield
Free cash flow $35.57M
Beta · 1Y 1.70
EBITDA · TTM −$54.98M
Gross margin 11.9%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 7
    The stock moved +24.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 7
  • Feb 25
    From its Feb 19 high, the share price fell 29%.

    Peak close $3.62 on Feb 19; trough close $2.57 on Feb 25. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -29%
  • Feb 25
    The stock moved -27.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 25

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$427.65M
Enterprise value$339.25M
Shares outstanding82.9M
52-wk range$2.30 – $9.78
Avg volume · 20D1.1M
Net cash $88.40M
Book value / share$2.60
IndustryWholesale-Lumber & Other Construction Materials
ExchangeNYSE
About Aspen Aerogels, Inc.
IPO dateJun 13, 2014
Employees854

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S1.86
P/FCF12.02
EV/EBITDA
EV/Sales1.47
Graham №

Profitability

Gross 11.9%
Operating -43.3%
Net -48.6%
FCF 15.4%
ROE / ROIC -27.0% · -80.5%

Financial Health

Current ratio2.89
Quick ratio2.54
Debt / equity0.40
Debt / EBITDA -1.55
Net cash $88.40M
Working capital$166.17M

Cash Flow · TTM

Operating CF $61.39M
Capex −$25.82M
Free cash flow $35.57M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

-2.1
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings